These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16891473)

  • 1. Clioquinol and docosahexaenoic acid act synergistically to kill tumor cells.
    Ding WQ; Liu B; Vaught JL; Palmiter RD; Lind SE
    Mol Cancer Ther; 2006 Jul; 5(7):1864-72. PubMed ID: 16891473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARalpha signaling mediates the synergistic cytotoxicity of clioquinol and docosahexaenoic acid in human cancer cells.
    Tuller ER; Brock AL; Yu H; Lou JR; Benbrook DM; Ding WQ
    Biochem Pharmacol; 2009 May; 77(9):1480-6. PubMed ID: 19426685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc-binding compounds induce cancer cell death via distinct modes of action.
    Ding WQ; Yu HJ; Lind SE
    Cancer Lett; 2008 Nov; 271(2):251-9. PubMed ID: 18639975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clioquinol independently targets NF-kappaB and lysosome pathways in human cancer cells.
    Yu H; Lou JR; Ding WQ
    Anticancer Res; 2010 Jun; 30(6):2087-92. PubMed ID: 20651355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer activity of the antibiotic clioquinol.
    Ding WQ; Liu B; Vaught JL; Yamauchi H; Lind SE
    Cancer Res; 2005 Apr; 65(8):3389-95. PubMed ID: 15833873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined inhibition of NF-κB and Bcl-2 triggers synergistic reduction of viability and induces apoptosis in melanoma cells.
    Watanabe M; Umezawa K; Higashihara M; Horie R
    Oncol Res; 2013; 21(4):173-80. PubMed ID: 24762223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitization of clioquinol and zinc in human cancer cell lines.
    Lu S; Ke Y; Wu C; Zhong Y; Xie C; Zhou Y; Zhou F; Yu H
    BMC Cancer; 2018 Apr; 18(1):448. PubMed ID: 29678153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docosahexaenoic acid and disulfiram act in concert to kill cancer cells: a mutual enhancement of their anticancer actions.
    Jiao Y; Hannafon BN; Zhang RR; Fung KM; Ding WQ
    Oncotarget; 2017 Mar; 8(11):17908-17920. PubMed ID: 28107189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential sensitization of cancer cells to doxorubicin by DHA: a role for lipoperoxidation.
    Mahéo K; Vibet S; Steghens JP; Dartigeas C; Lehman M; Bougnoux P; Goré J
    Free Radic Biol Med; 2005 Sep; 39(6):742-51. PubMed ID: 16109304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docosahexaenoic acid: a natural powerful adjuvant that improves efficacy for anticancer treatment with no adverse effects.
    Siddiqui RA; Harvey KA; Xu Z; Bammerlin EM; Walker C; Altenburg JD
    Biofactors; 2011; 37(6):399-412. PubMed ID: 22038684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of docosahexaenoic acid synergistically enhances the efficacy of apatinib for triple-negative breast cancer therapy.
    Ma Y; Yu J; Li Q; Su Q; Cao B
    Biosci Biotechnol Biochem; 2020 Apr; 84(4):743-756. PubMed ID: 31889475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clioquinol targets zinc to lysosomes in human cancer cells.
    Yu H; Zhou Y; Lind SE; Ding WQ
    Biochem J; 2009 Jan; 417(1):133-9. PubMed ID: 18764784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fish oil targets PTEN to regulate NFkappaB for downregulation of anti-apoptotic genes in breast tumor growth.
    Ghosh-Choudhury T; Mandal CC; Woodruff K; St Clair P; Fernandes G; Choudhury GG; Ghosh-Choudhury N
    Breast Cancer Res Treat; 2009 Nov; 118(1):213-28. PubMed ID: 18953692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitroxoline (8-hydroxy-5-nitroquinoline) is more a potent anti-cancer agent than clioquinol (5-chloro-7-iodo-8-quinoline).
    Jiang H; Taggart JE; Zhang X; Benbrook DM; Lind SE; Ding WQ
    Cancer Lett; 2011 Dec; 312(1):11-7. PubMed ID: 21899946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorafenib and docosahexaenoic acid act in synergy to suppress cancer cell viability: a role of heme oxygenase 1.
    Jiao Y; Watts T; Xue J; Hannafon B; Ding WQ
    BMC Cancer; 2018 Oct; 18(1):1042. PubMed ID: 30367621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer.
    Banerjee S; Zhang Y; Wang Z; Che M; Chiao PJ; Abbruzzese JL; Sarkar FH
    Int J Cancer; 2007 Feb; 120(4):906-17. PubMed ID: 17131310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor.
    Yu LL; Wu JG; Dai N; Yu HG; Si JM
    Oncol Rep; 2011 Nov; 26(5):1197-203. PubMed ID: 21811763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of apoptotic pathways in docosahexaenoic acid-induced benefit in prostate cancer: Pathway-focused gene expression analysis using RT
    Sun Y; Jia X; Hou L; Liu X; Gao Q
    Lipids Health Dis; 2017 Mar; 16(1):59. PubMed ID: 28330470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of the phosphoinostitide-3'-kinase delta inhibitor, CAL-101, in combination with Bortezomib on mantle lymophma cells and exploration of its related mechanism].
    Qu F; Xia B; Li X; Guo S; Zhang L; Tian C; Yu Y; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):412-7. PubMed ID: 26463142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent blockade of the NF-kappaB and Akt pathways potently sensitizes cancer cells to chemotherapeutic-induced cytotoxicity.
    He HN; Wang X; Zheng XL; Sun H; Shi XW; Zhong YJ; Huang B; Yang L; Li JK; Liao LC; Zhang L; Hu LN; Lin Y
    Cancer Lett; 2010 Sep; 295(1):38-43. PubMed ID: 20207071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.